Literature DB >> 19106153

Are drug-eluting stents safe in the long term?

Philippe Généreux1, Roxana Mehran.   

Abstract

Mesh：

Year:  2008        PMID： 19106153      PMCID： PMC2621276          DOI： 10.1503/cmaj.081907

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  10 in total

1.  Stent thrombosis in randomized clinical trials of drug-eluting stents.

Authors:  Laura Mauri; Wen-hua Hsieh; Joseph M Massaro; Kalon K L Ho; Ralph D'Agostino; Donald E Cutlip
Journal:  N Engl J Med       Date:  2007-02-12       Impact factor: 91.245

2.  Long-term outcomes of patients receiving drug-eluting stents.

Authors:  Andrew C Philpott; Danielle A Southern; Fiona M Clement; P Diane Galbraith; Mouhieddin Traboulsi; Merril L Knudtson; William A Ghali
Journal:  CMAJ       Date:  2008-12-18       Impact factor: 8.262

3.  Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study.

Authors:  Joost Daemen; Peter Wenaweser; Keiichi Tsuchida; Linda Abrecht; Sophia Vaina; Cyrill Morger; Neville Kukreja; Peter Jüni; Georgios Sianos; Gerrit Hellige; Ron T van Domburg; Otto M Hess; Eric Boersma; Bernhard Meier; Stephan Windecker; Patrick W Serruys
Journal:  Lancet       Date:  2007-02-24       Impact factor: 79.321

4.  Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

Authors:  Bo Lagerqvist; Stefan K James; Ulf Stenestrand; Johan Lindbäck; Tage Nilsson; Lars Wallentin
Journal:  N Engl J Med       Date:  2007-02-12       Impact factor: 91.245

5.  Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

Authors:  Adnan Kastrati; Julinda Mehilli; Jürgen Pache; Christoph Kaiser; Marco Valgimigli; Henning Kelbaek; Maurizio Menichelli; Manel Sabaté; Maarten J Suttorp; Dietrich Baumgart; Melchior Seyfarth; Matthias E Pfisterer; Albert Schömig
Journal:  N Engl J Med       Date:  2007-02-12       Impact factor: 91.245

6.  Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

Authors:  Gregg W Stone; Jeffrey W Moses; Stephen G Ellis; Joachim Schofer; Keith D Dawkins; Marie-Claude Morice; Antonio Colombo; Erick Schampaert; Eberhard Grube; Ajay J Kirtane; Donald E Cutlip; Martin Fahy; Stuart J Pocock; Roxana Mehran; Martin B Leon
Journal:  N Engl J Med       Date:  2007-02-12       Impact factor: 91.245

7.  Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.

Authors:  Ioannis Iakovou; Thomas Schmidt; Erminio Bonizzoni; Lei Ge; Giuseppe M Sangiorgi; Goran Stankovic; Flavio Airoldi; Alaide Chieffo; Matteo Montorfano; Mauro Carlino; Iassen Michev; Nicola Corvaja; Carlo Briguori; Ulrich Gerckens; Eberhard Grube; Antonio Colombo
Journal:  JAMA       Date:  2005-05-04       Impact factor: 56.272

8.  Drug-eluting or bare-metal stents for acute myocardial infarction.

Authors:  Laura Mauri; Treacy S Silbaugh; Pallav Garg; Robert E Wolf; Katya Zelevinsky; Ann Lovett; Manu R Varma; Zheng Zhou; Sharon-Lise T Normand
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

9.  Effectiveness and safety of drug-eluting stents in Ontario.

Authors:  Jack V Tu; James Bowen; Maria Chiu; Dennis T Ko; Peter C Austin; Yaohua He; Robert Hopkins; Jean-Eric Tarride; Gord Blackhouse; Charles Lazzam; Eric A Cohen; Ron Goeree
Journal:  N Engl J Med       Date:  2007-10-04       Impact factor: 91.245

Review 10.  Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.

Authors:  Christoph Stettler; Simon Wandel; Sabin Allemann; Adnan Kastrati; Marie Claude Morice; Albert Schömig; Matthias E Pfisterer; Gregg W Stone; Martin B Leon; José Suarez de Lezo; Jean-Jacques Goy; Seung-Jung Park; Manel Sabaté; Maarten J Suttorp; Henning Kelbaek; Christian Spaulding; Maurizio Menichelli; Paul Vermeersch; Maurits T Dirksen; Pavel Cervinka; Anna Sonia Petronio; Alain J Nordmann; Peter Diem; Bernhard Meier; Marcel Zwahlen; Stephan Reichenbach; Sven Trelle; Stephan Windecker; Peter Jüni
Journal:  Lancet       Date:  2007-09-15       Impact factor: 79.321
  10 in total
  2 in total

Review 1.  Explanatory models are needed to integrate RCT and observational data with the patient's unique biology.

Authors:  Vijay Sharma; Rubin Minhas
Journal:  J R Soc Med       Date:  2012-01       Impact factor: 5.344

2.  Use of drug-eluting stents versus bare-metal stents in Korea: a cost-minimization analysis using population data.

Authors:  Hae Sun Suh; Hyun Jin Song; Eun Jin Jang; Jung-Sun Kim; Donghoon Choi; Sang Moo Lee
Journal:  J Prev Med Public Health       Date:  2013-07-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.